Sex differences in depressive and socioemotional responses to an inflammatory challenge: Implications for sex differences in depression

Neuropsychopharmacology

Volumn 40, Issue 7, 2015, Pages 1709-1716

  Moieni, Mona ^a   Irwin, Michael R ^b   Jevtic, Ivana ^a   Olmstead, Richard ^b   Breen, Elizabeth C ^b   Eisenberger, Naomi I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BLOOD; COMPLICATION; DEPRESSION; FEMALE; HUMAN; ILLNESS BEHAVIOR; INFLAMMATION; MALE; PHYSIOLOGY; PSYCHOLOGY; SELF REPORT; SEXUAL DEVELOPMENT; SOCIAL BEHAVIOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CYTOKINES; DEPRESSION; FEMALE; HUMANS; ILLNESS BEHAVIOR; INFLAMMATION; MALE; SELF REPORT; SEX CHARACTERISTICS; SOCIAL BEHAVIOR; YOUNG ADULT;

EID: 84939977643     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.17     Document Type: Article

References (51)

1. Andreasen A, Krabbe K, Krogh-Madsen R, Taudorf S, Pedersen B, Moller K (2008). Human endotoxemia as a model of systemic inflammation. Curr Med Chem 15: 1697-1705.
2. Baker F, Denniston M, Zabora J, Polland A, Dudley WN (2002). A POMS short form for cancer patients: psychometric and structural evaluation. Psycho-Oncology 11: 273-281.
3. Beck AT, Steer RA, Carbin MG (1988). Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8: 77-100.
4. Bonaccorso S, Marino V, Biondi M, Grimaldi F, Ippoliti F, Maes M (2002). Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. J Affect Disord 72: 237-241.
5. Breen E, Perez C, Olmstead R, Eisenberger N, Irwin M (2014). 135. Comparison of multiplex immunoassays and ELISAs for the determination of circulating levels of inflammatory cytokines. Brain Behav Immun 40: e39.
6. Bremmer M, Beekman A, Deeg D, Penninx B, Dik M, Hack C et al (2008). Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 106: 249-255.
7. Cartier A, Côté M, Lemieux I, Pérusse L, Tremblay A, Bouchard C et al (2009). Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am J Clin Nutr 89: 1307-1314.
8. Chapman BP, Khan A, Harper M, Stockman D, Fiscella K, Walton J et al (2009). Gender, race/ethnicity, personality, and interleukin-6 in urban primary care patients. Brain Behav Immun 23: 636-642.
9. Covic T, Cumming SR, Pallant JF, Manolios N, Emery P, Conaghan PG et al (2012). Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry 12: 6.
10. Cyranowski JM, Frank E, Young E, Shear MK (2000). Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model. Arch Gen Psychiatry 57: 21-27.
11. Duivis HE, de Jonge P, Penninx BW, Na BY, Cohen BE, Whooley MA (2011). Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry 168: 913-920.
12. Eisenberger NI, Inagaki TK, Mashal NM, Irwin MR (2010). Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav Immun 24: 558-563.
13. Eisenberger NI, Inagaki TK, Rameson LT, Mashal NM, Irwin MR (2009). An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. NeuroImage 47: 881-890.
14. Epstein MM, Breen EC, Magpantay L, Detels R, Lepone L, Penugonda S et al (2013). Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men. Cancer Epidemiol Biomarkers Prev 22: 2009-2015.
15. Fuller-Thomson E, Shaked Y (2009). Factors associated with depression and suicidal ideation among individuals with arthritis or rheumatism: findings from a representative community survey. Arthritis Care Res 61: 944-950.
16. Gimeno D, Kivimäki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A et al (2009). Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 39: 413-423.
17. Gohier B, Goeb J-L, Rannou-Dubas K, Fouchard I, Calès P,Garré J-B (2003). Hepatitis C, alpha interferon, anxiety and depression disorders: a prospective study of 71 patients. World J Biol Psychiatry 4: 115-118.
18. Grigoriadis S, Robinson GE (2007). Gender issues in depression. Ann Clin Psychiatry 19: 247-255.
19. Hankin BL, Abramson LY (2001). Development of gender differences in depression: an elaborated cognitive vulnerability-transactional stress theory. Psychol Bull 127: 773.
20. Hannestad J, DellaGioia N, Ortiz N, Pittman B, Bhagwagar Z (2011). Citalopram reduces endotoxin-induced fatigue. Brain Behav Immun 25: 256-259.
21. Heinrich LM, Gullone E (2006). The clinical significance of loneliness: a literature review. Clin Psychol Rev 26: 695-718.
22. Howren MB, Lamkin DM, Suls J (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71: 171-186.
23. Hyde JS, Mezulis AH, Abramson LY (2008). The ABCs of depression: integrating affective, biological, and cognitive models to explain the emergence of the gender difference in depression. Psychol Rev 115: 291.
24. Joiner TE, Lewinsohn PM, Seeley JR (2002). The core of loneliness: Lack of pleasurable engagement-more so than painful disconnection - predicts social impairment, depression onset, and recovery from depressive disorders among adolescents. J Pers Assess 79: 472-491.
25. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB (1993). Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 29: 85-96.
26. Koskinas J, Merkouraki P, Manesis E, Hadziyannis S (2003). Assessment of depression in patients with chronic viral hepatitis: effect of interferon treatment. Dig Dis 20: 284-288.
27. Kuehner C (2003). Gender differences in unipolar depression: an update of epidemiological findings and possible explanations. Acta Psychiatr Scand 108: 163-174.
28. Margaretten M, Julian L, Katz P, Yelin E (2011). Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumatol 6: 617-623.
29. McNair DM, Lorr M, Droppleman LF (1971). Manual for the Profile of Mood States. Education and Industrial Testing Service: San Diego, CA.
30. Nolen-Hoeksema S (2001). Gender differences in depression. Curr Direct Psychol Sci 10: 173-176.
31. Nolen-Hoeksema S, Girgus JS (1994). The emergence of gender differences in depression during adolescence. Psychol Bull 115: 424.
32. O'Connor M-F, Motivala SJ, Valladares EM, Olmstead R, Irwin MR (2007). Sex differences in monocyte expression of IL-6: role of autonomic mechanisms. Am J Physiol Regul Integr Compar Physiol 293: R145-R151.
33. Osborne JW, Overbay A (2004). The power of outliers (and why researchers should always check for them). Pract Assess Res Eval 9: 1-12.
34. Patten S, Beck C, Williams J, Barbui C, Metz L (2003). Major depression in multiple sclerosis: a population-based perspective. Neurology 61: 1524-1527.
35. Patten SB, Metz LM, Reimer MA (2000). Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Mult Scler 6: 115-120.
36. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S et al (2003). Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 54: 566-572.
37. Prather AA, Carroll JE, Fury JM, McDade KK, Ross D, Marsland AL (2009). Gender differences in stimulated cytokine production following acute psychological stress. Brain Behav Immun 23: 622-628.
38. Raison CL, Capuron L, Miller AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27: 24-31.
39. Raison CL, Miller AH (2011). Is depression an inflammatory disorder? Curr Psychiatry Rep 13: 467-475.
40. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A et al (2001). Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58: 445-452.
41. Russell DW (1996). UCLA Loneliness Scale (Version 3): reliability, validity, and factor structure. J Pers Assess 66: 20-40.
42. Schedlowski M, Engler H, Grigoleit J-S (2014). Endotoxin-induced experimental systemic inflammation in humans: A model to disentangle immune-to-brain communication. Brain Behav Immun 35: 1-8.
43. Steptoe A, Hamer M, Chida Y (2007). The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav Immun 21: 901-912.
44. Steptoe A, Owen N, Kunz-Ebrecht S, Mohamed-Ali V (2002). Inflammatory cytokines, socioeconomic status, and acute stress responsivity. Brain Behav Immun 16: 774-784.
45. Suffredini AF, O'Grady NP (1999). Pathophysiological responses to endotoxin in humans. In: Braude H, Opal SM, Vogel SN, Morrison DC. (Eds.), Endotoxin in Health and Disease, First Ed. Marcel Dekker, New York, pp. 817-830.
46. Suffredini AF, Fantuzzi G, Badolato R, Oppenheim JJ, O'Grady NP (1999b). New insights into the biology of the acute phase response. J Clin Immunol 19: 203-214.
47. Van Breukelen GJ (2006). ANCOVA versus change from baseline had more power in randomized studies and more bias in nonrandomized studies. J Clin Epidemiol 59: 920-925.
48. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu H-G et al (1996). Cross-national epidemiology of major depression and bipolar disorder. JAMA 276: 293-299.
49. Weissman MM, Klerman GL (1977). Sex differences and the epidemiology of depression. Arch Gen Psychiatry 34: 98.
50. Whitacre CC (2001). Sex differences in autoimmune disease. Nat Immunol 2: 777-780.
51. Winkens B, van Breukelen GJ, Schouten HJ, Berger MP (2007). Randomized clinical trials with a pre-and a post-treatment measurement: repeated measures versus ANCOVA models. Contemp Clin Trials 28: 713-719.